Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma

International Journal of Clinical Oncology

Volumn 18, Issue 5, 2013, Pages 829-838

  Horino, Kei ^a   Beppu, Toru ^a   Kuroki, Hideyuki ^a   Mima, Kosuke ^a   Okabe, Hirohisa ^a   Nakahara, Osamu ^a   Ikuta, Yoshiaki ^a   Chikamoto, Akira ^a   Ishiko, Takatoshi ^a   Takamori, Hiroshi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Prognosis

Indexed keywords

ALBUMIN; BILIRUBIN; C REACTIVE PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; INDOCYANINE GREEN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CANCER PATIENT; CHILD PUGH SCORE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; GLASGOW PROGNOSTIC SCORE; HEPATIC VEIN INVASION; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTAL VEIN INVASION; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SEX; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PORTAL VEIN; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84886090727     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0451-3     Document Type: Article

References (25)

1. Poon RT, Ng IO, Fan ST et al (2001) Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 19(12):3037-3044
2. Sumie S, Kuromatsu R, Okuda K et al (2008) Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15(5):1375-1382
3. Katz SC, Shia J, Liau KH et al (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249(4):617-623
4. Cho SY, Park SJ, Kim SH et al (2010) Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol 17(7):1823-1830
5. Ramacciato G, Nigri G, Bellagamba R et al (2010) Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg 76(11):1260-1268
6. Muratore A, Ribero D, Zimmitti G et al (2010) Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 17(5):1324-1329
7. Pathak S, Tang JM, Terlizzo M et al (2010) Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases. Eur J Surg Oncol 36(1):52-57
8. Masuda T, Beppu T, Horino K et al (2010) Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma. J Surg Oncol 102(5):490-496
9. Arii S, Tanaka J, Yamazoe Y et al (1992) Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 69(4):913-919
10. Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646-649
11. Haider M, Haider SQ (1984) Assessment of protein-calorie malnutrition. Clin Chem 30(8):1286-1299
12. Forrest LM, McMillan DC, McArdle CS et al (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89(6):1028-1030
13. Forrest LM, McMillan DC, McArdle CS et al (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90(9):1704-1706
14. Ishizuka M, Nagata H, Takagi K et al (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246(6):1047-1051
15. Kobayashi T, Teruya M, Kishiki T et al (2010) Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival. Dig Surg 27(4):285-290
16. Al Murri AM, Bartlett JM, Canney PA et al (2006) Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94(2):227-230
17. Vashist YK, Loos J, Dedow J et al (2011) Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer. Ann Surg Oncol 18(4):1130-1138
18. Shimoda M, Katoh M, Kita J et al (2010) The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer. Chemotherapy 56(6):501-506
19. Fujiwara Y, Shiba H, Furukawa K et al (2010) Glasgow prognostic score is related to blood transfusion requirements and post-operative complications in hepatic resection for hepatocellular carcinoma. Anticancer Res 30(12):5129-5136
20. Ishizuka M, Kubota K, Kita J et al (2011) Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma. J Surg Oncol 103(8):801-806
21. Su CH, Tsay SH, Wu CC et al (1996) Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223(4):384-394
22. Ueno S, Tanabe G, Nuruki K et al (2002) Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepatobiliary Pancreat Surg 9(4):469-477
23. Ichikawa T, Uenishi T, Takemura S et al (2009) A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 16(1):42-48
24. McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67(3):257-262
25. Ji J, Shi J, Budhu A et al (2009) MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361(15):1437-1447